Dengyan Ma
About
In The Last Decade
Dengyan Ma
12 papers receiving 751 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Pathology and Forensic Medicine 541
- Oncology 347
- Genetics 317
- Radiology, Nuclear Medicine and Imaging 198
- Immunology 146
Countries citing papers authored by Dengyan Ma
This map shows the geographic impact of Dengyan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dengyan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dengyan Ma more than expected).
Fields of papers citing papers by Dengyan Ma
This network shows the impact of papers produced by Dengyan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dengyan Ma. The network helps show where Dengyan Ma may publish in the future.
Co-authorship network of co-authors of Dengyan Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Dengyan Ma. A scholar is included among the top collaborators of Dengyan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dengyan Ma. Dengyan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | 15 | |
| 14 | 23 | |
| 15 | Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. breakdown → | 724 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.